insulin
Onglyza cleared for use with insulin
November 29, 2011Sales and Marketing AstraZeneca, Merck, Onglyza, diabetes, insulin
European regulators have approved a licence extension for Bristol-Myers Squibb and AstraZeneca’s type II diabetes treatment Onglyza. The oral DPP-4 …
NHS ‘wasted’ £625 million on modern insulin
September 23, 2011Sales and Marketing diabetes, insulin
The NHS has wasted £625 million on modern insulin products over the last decade, according to a new report in …
Afrezza could breathe new life into inhaled insulin market
August 15, 2011Research and Development, Sales and Marketing diabetes, inhaled insulin, insulin, research and development news
New trials for MannKind’s investigational inhaled insulin drug Afrezza have been given the go-ahead by the FDA, potentially breathing new …
Treatment flexibility will improve adherence in diabetes, study suggests
June 29, 2011Research and Development, Sales and Marketing diabetes, insulin
A third of patients with diabetes admit to regularly missing or not taking insulin treatment three days a month, according …
New product can overtake Lantus, says Novo leader
May 11, 2011Sales and Marketing Novo Nordisk, degludec, diabetes, insulin
Novo Nordisk’s new insulin product can eclipse Sanofi’s Lantus within just a few years of its launch, according to Novo’s …
Novo to develop oral insulin
December 22, 2010Research and Development Emisphere, Novo Nordisk, diabetes, insulin, oral insulin, type I diabetes
Novo Nordisk is to develop an oral formulation of insulin with US biotech company Emisphere Technologies. The New Jersey-based biotech …
Merck acquires innovative insulin firm SmartCells
December 3, 2010Research and Development Merck, Merck & Co, SmartCells, diabetes, insulin
Merck has bolstered its early stage diabetes portfolio with the acquisition of SmartCells, a private pharma firm that’s developing a …
Novo Nordisk invests $73m to boost diabetes drug production
October 8, 2010Manufacturing and Production Novo Nordisk, diabetes, insulin
Novo Nordisk has announced another major expansion of its manufacturing capacity for diabetes products, setting aside $73 million to expand …
Novo agrees price cut deal with Greece
June 16, 2010Sales and Marketing Greece, Novo Nordisk, insulin, pricing
Novo Nordisk has agreed to resume supply of its insulins to the Greek market after pulling them last month as …
Latest content
